Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emit Imaging provides the Xerra™ CFT system and related services to enable high-resolution ex vivo volumetric imaging of drug distribution, protein expression, gene therapy vectors, tumor biology, and more. Their technology bridges the gap between cellular microscopy and whole-body imaging modalities like MRI/PET by providing detailed three-dimensional fluorescence images for preclinical research. The company collaborates with leading academic centers such as MIT Koch Institute to further develop its workflow for cancer research applications. No clinical results are reported since they do not develop drugs directly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emit Imaging.